Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa) (MMENSEA)

February 22, 2022 updated by: University Hospital Center of Martinique

Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination

The main objective of the study is to analyze the psychometric properties of the "antillanisée" version of the Mini Mental State Examination (MMSEa).

The methodology used will permit to explore the feasibility, acceptability, validity and reliability of the tool.

The psychometric validation of a version adapted transculturally will increase the value of the results obtained with this test and will make it possible to refine the screening of existing cognitive disorders for elderly subjects with Alzheiner's disease or related disorders.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Patients will be recruited at the Geriatric Day Hospital.

These patients came to a geriatric day hospital for examination without restriction on the reason for the hospitalization.

They are referred by their general practitionner or referred by a specialist physician, live at home or in an institution and are representative of the geriatric population addressed by the MMSEa.

  • The main objective of the study is to analyze the psychometric properties of the "antillanisée" version of the Mini Mental State Examination (MMSEa).
  • The ancillary objective of this study will be to carry out the psychometric validation of the Short Physical Performance Battery (SPPB) in people aged 65 years or older.

It is an instrument for measuring the physical performance of subjects whose transcultural adaptation and psychometric validation have already been performed in subjects aged 65 to 74 years.

SPPB is used routinely in our routine practice in a day hospital, with no psychometric validation performed on this population. This ancillary objective will not modify the course of the MMSEa validation study since the SPPB is part of the evaluation tools.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Martinique
      • Fort-de-France, Martinique, France, 97200
        • CHU de Martinique

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject of 65 years old and over
  • Subject admitted in a geriatric day hospital
  • Patients of creole culture
  • Subject having French and/or Creole as mother tongue
  • Subject able to undergo neuropsychological tests
  • Subject having given informed consent or, informed consent given by his or her primary caregiver
  • Subject affiliated to a social security scheme

Exclusion Criteria:

  • Subject with a disability seriously compromising oral communication (understanding and expression)
  • Subject with behavioral disorder that does not allow for testing
  • Subject in general condition not allowing its participation in the tests
  • Subject involved in another study including an exclusion period still in progress at the time of inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Elderly patient (65 and more)
Ederly patients seen in geriatric day hospital, from creole culture.
Diagnostic test: "Antillanisée" Mini Mental State Examination (MMSEa)
"Antillanisée" version of the Mini Mental State Examination (MMSEa), is a version adaptated to the French West Indies creole culture.
Other Names:
  • MMSEa

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the psychometric properties of the questionnaire MMSEa
Time Frame: 12 month (+/- 15 days)

The following will be measured:

  • feasibility and acceptability;
  • validity of structure;
  • discriminant validity;
  • predictive validity;
  • validity of convergence;
  • reliability (internal consistency,reproducibility (test-retest)).
12 month (+/- 15 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the psychometric properties of questionnaire SPPB
Time Frame: 12 month (+/- 15 days)

The following will be measured:

  • feasibility and acceptability;
  • validity of structure;
  • discriminant validity;
  • predictive validity;
  • reliability (internal consistency,reproducibility (test-retest)).
12 month (+/- 15 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital Center of Martinique

Investigators

  • Principal Investigator: Lidvine GODAERT-SIMON, MD, CHU of Martinique

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 15, 2016

Primary Completion (ACTUAL)

April 11, 2019

Study Completion (ACTUAL)

July 1, 2019

Study Registration Dates

First Submitted

January 11, 2017

First Submitted That Met QC Criteria

October 24, 2017

First Posted (ACTUAL)

October 30, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 9, 2022

Last Update Submitted That Met QC Criteria

February 22, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15/B/26

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

Clinical Trials on "Antillanisée" Mini Mental State Examination (MMSEa)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe